title: Decrease in the haemoglobin level in haemodialysis patients undergoing antiandrogen therapy.
authors.affiliation: Servicio de Nefrología, Hospital Ramón y Cajal, Madrid, Spain.
authors.forename: J L
authors.initials: JL
authors.lastname: Teruel
authors.forename: T
authors.initials: T
authors.lastname: Cano
authors.forename: R
authors.initials: R
authors.lastname: Marcén
authors.forename: J J
authors.initials: JJ
authors.lastname: Villafruela
authors.forename: M
authors.initials: M
authors.lastname: Rivera
authors.forename: G
authors.initials: G
authors.lastname: Fernández-Juarez
authors.forename: J
authors.initials: J
authors.lastname: Ortuño
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005485:Flutamide / Q000008:administration & dosage; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy; D006435:Renal Dialysis
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D006454:Hemoglobins; D005485:Flutamide; D016729:Leuprolide